March 21, 2016 at 06:57PM FDA Approves Galliprant, a New Animal Drug for Osteoarthritis in Dogs

The U.S. Food and Drug Administration today announced the approval of Galliprant (grapiprant tablets), a new animal drug intended to control pain and inflammation associated with osteoarthritis in dogs.

via What's New: Animal & Veterinary http://ift.tt/1WD4KqY